Table 1 Clinical findings of patients with amyotrophic lateral sclerosis and of control subjects
Case no. | Age at death (years) | Gender | Diagnosis | Postmortem delay (hours) | Duration of illness (months) | Percentage of VCP-positive nuclei |
|---|---|---|---|---|---|---|
Control | cases | Â | Â | Â | Â | Â |
1 | 75 | M | Chronic lymphocitic leukemia | 2.5 | NA | 0 |
2 | 75 | M | Cerebral infarction | 1 | NA | 0 |
3 | 86 | M | Cerebral infarction | 5 | NA | 0 |
4 | 75 | M | Meningitis | 3 | NA | 1.7 |
5 | 83 | F | Intracerebral hemorrhage | 12 | NA | 4 |
6 | 52 | M | Cerebral infarction | 12 | NA | 8.9 |
7 | 50 | F | Myotonic Dystrophy | 10 | NA | 0 |
8 | 60 | M | Myasthenia Gravis | 2.5 | NA | 0 |
ALS cases | Â | Â | Â | Â | Â | Â |
9 | 54 | F | SALS | 3.5 | 11 | 26.3 |
10 | 82 | M | SALS | 1.5 | 14 | 0 |
11 | 62 | M | SALS | 1.5 | 14 | 0 |
12 | 56 | F | SALS | 22.5 | 20 | 0 |
13 | 65 | M | SALS | 1.5 | 23 | 8.3 |
14 | 63 | M | SALS | 1.5 | 23 | 15 |
15 | 64 | M | SALS | 3 | 24 | 17.6 |
16 | 65 | M | SALS | 16 | 24 | 94.1 |
17 | 58 | F | SALS | 3.5 | 35 | 47.1 |
18 | 41 | M | VCP-ALS | 2 | 48 | 7.7 |